Cutera, Inc.  

(Public, NASDAQ:CUTR)   Watch this stock  
Find more results for Cutera
9.61
+0.13 (1.37%)
May 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.33 - 9.73
52 week 6.33 - 14.14
Open 9.43
Vol / Avg. 50,002.00/172,441.00
Mkt cap 135.76M
P/E     -
Div/yield     -
EPS -0.47
Shares 14.13M
Beta 0.97
Inst. own 67%
Aug 5, 2013
Q2 2013 Cutera, Inc. Earnings Release Add to calendar
Jun 19, 2013
Cutera, Inc. Annual Shareholder Meeting - 1:00PM EDT - Add to calendar
May 10, 2013
Q1 2013 Cutera, Inc. Earnings Release
May 6, 2013
Q1 2013 Cutera, Inc. Earnings Conference Call - Webcast
Mar 19, 2013
Cutera, Inc. at Roth Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin 4.78% -8.47%
Operating margin 4.74% -8.83%
EBITD margin - -7.87%
Return on average assets 3.89% -5.84%
Return on average equity 4.84% -7.18%
Employees 200 -
Carbon Disclosure Rating - -

Address

3240 Bayshore Boulevard
BRISBANE, CA 94005
United States - Map
+1-415-6575500 (Phone)
+1-415-3302444 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Cutera, Inc. is a global medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and light-based aesthetics systems for practitioners worldwide. The Company offers products based on six platforms, which include CoolGlide, Xeo, Solera, GenesisPlus, Excel V, and myQ. Each of the Company's laser and light-based platforms consists of one or more hand pieces and a console that incorporates a graphic user interface, a laser or light-based module, control system software and high voltage electronics. In addition to systems and upgrades, the Company generates revenue from the sale of post warranty services, Titan hand piece refills, and Dermal filler and cosmeceuticals. Its CoolGlide, Xeo, Solera, GenesisPlus, Excel V and myQ platforms provide the benefits of laser and light-based aesthetic treatments. On February 2, 2012, it completed its acquisition of certain assets of IRIDEX Corporation�s (IRIDEX) global aesthetic business.

Officers and directors

Kevin P. Connors President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Ronald J. Santilli Chief Financial Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
David B. Apfelberg M.D. Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
David A. Gollnick Director
Age: 48
Bio & Compensation  - Reuters
Gregory Barrett Independent Director
Age: 58
Bio & Compensation  - Reuters
W. Mark Lortz Independent Director
Age: 61
Bio & Compensation  - Reuters
Timothy J. O'Shea Independent Director
Age: 59
Bio & Compensation  - Reuters